John has joined Bayer Healthcare almost 4 years ago and in this function he is responsible for Global end to end supply chain for all 4 divisions. In this function he has strategic and tactical responsibilities for the world wide availability of product. In the last 3 years John lead the program to optimize inventories and increase its service levels and this resulted in a 600 million Cash improvement and an increased service level for all divisions.

John is a trained officer of the Dutch Marines (Platoon Commander) and studied business engineering in Eindhoven and holds an international executive MBA from IBO in Zeist.

Key supply chain project you are currently working on:
Lean supply chain (lead time reduction), Supplier integration and process standardization.

What is your major investment area within the supply chain?
One Global ERP tool and SCM knowledge improvement

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Decomplexation of our supply chain (tools and processes)

What benefits do plan to take home from LogiPharma?
Creative SCM thoughts and possible SCM collaboration with a few industry colleagues for the near future

Andy has worked in AZ for 22 years (through ICI, Zeneca and then AstraZeneca) joining originally as a Chemical Engineer and have worked across all parts of the supply chain. In my early career I held a variety of Engineering and Production Management roles which included working in France More recent roles have including Global Supply Chain Manager, Engineering Manager for an API site undergoing major expansion, establishing a new logistics department on one of AZ's largest manufacturing sites and then subsequently leading it plus the Packaging Manufacturing during a major Lean transformation. Present role is the Business Lead for the roll-out of SAP APO across the business.

Key supply chain project you are currently working on:
Global S & OP, Segmentation and improved planning and synchronisation along the supply chain and improving the professional capabilities of our Planning community

What is your major investment area within the supply chain?
EERP consolidation, roll-out of SAP SCM

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Improved inventory management and better customer service and looking to significantly improve our end to end supply chain planning to drive improvements in these two areas. Also improved risk management and forecasting in our supply chains.

What benefits do you plan to take home from LogiPharma?
Learn from best practises in other organisations and take the opportunity to build a broader network across the Pharma Industry

Hans-Walter Hoehl became VP of Strategy & Projects at Bayer HealthCare Global Pharmaceutical Production in January 2011. He is responsible for defining the manufacturing strategy and executing key projects to optimize the operational and financial performance of BHC Pharmaceuticals’ five supply centers and twelve regional manufacturing sites. He leads a team of operational excellence specialists who initiate and support lean transformations in the major sites and functions.

With over 30 years’ experience, Hans-Walter has a broad background in Bayer’s subgroups Crop Science and central functions R&D and Engineering where he held roles in process development for active ingredients and in managing major investment projects. He joined the pharmaceutical division in 1992 where he was leading the regional site operations for 7 years and supply chain management for 10 years. After the Schering acquisition in 2006, he was responsible for integrating the supply chain functions of both companies. Since 2007, he deals with product coding and serialization as head of a Bayer HealthCare task force and as member of EFPIA’s Senior Oversight Group.
Hans-Walter worked in Italy for four years and is now based in Berlin, Germany.

Key supply chain project you are currently working on:
Lean Transformation of three major supply centers.

What is your major investment area within the supply chain?
Optimization of throughput time to minimize working capital and increase flexibility and responsiveness.
Product coding and serialization.

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Global launches of products with blockbuster potential, to be overcome with dedicated launch teams.

What benefits do you plan to take home from LogiPharma?
Networking, learn about supply chain strategies.

Hervé Udriot is Ferring's VP Global Supply Chain since 2008. A PhD in Chemical Engineering and Biotechnology, he has worked in Manufacturing and Supply Chain roles during a 20 year career in the Pharmaceutical and Chemical industry, including site management at companies such as Novartis and Huntsman. At Ferring, he is in charge of Procurement and Supply Chain management, and he has responsibility for Third Party Manufacturing activities as well as for Ferring's manufacturing sites in Latin America and Asia.

Matt Shaughnessy is Head of Distribution for AstraZeneca in the EMEA region. He has worked in the Pharma industry for over 20 years. After starting his career in R&D, Matt moved to Supply Chain in 2000 and has held a number of roles in manufacturing, project management and logistics.

Matt is particularly interested in establishing new supply chain solutions working in partnership with other functions and organisations. He has wide experience in the EMEA Region and is currently spending his time working with the diverse range of opportunities and challenges in the Region.

Matt is motivated by leading and developing large teams across a number of countries.

Key supply chain project you are currently working on:
Establishing a new distribution network in the Middle East and Africa

What is your major investment area within the supply chain?
New assets to support market access

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Delivering excellent customer service in volatile markets through more efficient and responsive supply chains

What benefits do you plan to take home from LogiPharma?
New ideas and new opportunities to collaborate

After nearly 20 years with GlaxoSmithKline covering a wide variety of technical, production and supply chain roles, Stuart joined Novartis Vaccines 4 years ago as Head of Supply Chain. Since then his role has expanded to include responsibility for systems and business processes associated with Supply Chain.

In his current role, Stuart is accountable for all planning, warehousing, artwork and cold chain distribution operations around the vaccines global network (6 sites) and working with colleagues within the global Supply Chain Management and Strategy group. The biggest challenge in recent times, the H1N1 Flu Pandemic, brought new learnings to Novartis (and other companies) about risk management, cold chain distribution and integrated planning.

Stuart holds a BSC (Hons) in Chemical and Process Engineering from Heriot Watt University, in Edinburgh.

Steven has 9 years experience in logistic automation projects all over Europe for a Belgian based company (mainly Pharma and retail customers). He also has 3 years experience in warehousing (build, implement systems and managing the warehouse) for the worldwide distribution center for pharma and 2 years experience in logistic (distribution and warehousing) in the FMCG.

For the last 2 years, Steven has held the position of Head of European Warehousing & Transportation and International Freight for Teva Pharmaceutical, working out centralized transportation management and network optimization for warehousing and transportation looking for EU synergies and improvements

Stuart Anderson achieved his degrees in Chemical Engineering and Pharmacy at Sydney University. He joined Astra Pharmaceuticals as a Process Engineer in 1987 and subsequently held a number of roles in Production Management, Technical Management, QA and Development. In 1997, Stuart became the site lead and Manufacturing Director at Astra in Sydney. In 2000, he moved into the commercial operations for AstraZeneca as Sales and Marketing Director for Hospital and Oncology for the Australian Market. In 2003, he became Integrated Services Director for AstraZeneca which was a role working across various markets in Asia Pacific as well as holding responsibility for IS, Procurement and Corporate Services. In 2006, he returned as the Director of Manufacturing and in 2008 took up a new role in the Asia Pacific and Japan Regional office located in Singapore as Regional Supply Director for AstraZeneca. In 2011, he moves into the Global organisation for AstraZeneca as Head of Global Supply Chain and Strategy Enabling Capabilities located in the UK. In his current role Stuart is responsible for a number of global supply functions including Product Security, Packaging, Distribution, governance and Assurance, Innovation and Projects and Change Management.

Key supply chain project you are currently working on:
Formulating a transformational Supply Chain Strategy towards Value Chain way of working

What is your major investment area within the supply chain?
ERP systems and capability development materials

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Setting in place basic improvements to set a solid foundation for the future strategy execution as above

What benefits do you plan to take home from LogiPharma?
Networking, understanding new perspectives

Ann Merchant is President of Schreiner MediPharm, a business unit of Schreiner Group based in Oberschleissheim near Munich in Germany. Schreiner MediPharm develops and produces innovative, multi-functional specialty labels with value-added benefits for the pharmaceutical industry. Ann is responsible for the sales organization, global strategy and further development of the business unit building on the worldwide network of sales representatives and local US production.

Prior to joining Schreiner MediPharm, Ann was VP International Supply Chain for Amgen Europe BV in The Netherlands. There she was responsible for Amgen Inc.´s sole international packaging and distribution facility as well as Operation´s primary point of contact for international expansion efforts in Middle East Africa, CEE and South America. She has over 20 years of pharmaceutical industry experience in the areas of financial planning, strategic decision support and global commercial supply strategy at both the corporate and affiliate level in the US and Europe.

Ann holds a BSc in Languages from Georgetown University in Washington D.C., and a Master in Business Administration from Henley Management College, UK.

Arjan is executive Director Supply Chain at Alexion Pharma International. He leads a team of 5 persons and managers, excluding several Supply Chain managers in the regions. Arjan’s major challenges for 2012 is to roll-out full traceability capabilities in the EU AND other more sensitive regions, as well as implementing a strong Risk Mitigation Action Plan. He hopes to meet likeminded professionals to share and benchmark against international best-in-class companies.
As Dutch citizen Arjan loves skiing and mountain biking.

Key supply chain project you are currently working on:
• Supply Chain Risk mitigation (multi sourcing, track & Trace)
• New Product introductions
• Reduction distribution costs 

What is your major investment area within the supply chain?
Software (track and trace, artwork management process)

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Qualification new manufacturing site for fill & finish + labeling/packaging. We will recruit additional resources with different skills

What benefits do you plan to take home from LogiPharma?
• Benchmarking with other Biotech companies
• Networking
• Learn from “best-in-class”-biotech supply chains

Frank Binder is Director, International Logistics and Supply Chain, at Celgene, based in Switzerland. Currently his main task is expanding and managing Celgene’s international pharmaceutical logistics setup, optimizing the European distribution network while building a new distribution network across Asia. He is guided by his team’s mission statement : “Products to the Patients – Every Time, On Time – Compliant & Cost-effective”.

Prior to Celgene, Frank has worked in various Supply Chain roles at Hoffmann-La Roche, Novartis and at management consultancy Accenture. Thereby he’s gained a broad and deep Supply Chain Management expertise in the Pharmaceutical Industry, ranging from chemical production, biopharmaceutical manufacturing capacity planning, to logistics at a galenical manufacturing site, and finally to international logistics and distribution.

Frank has been involved in many projects (mergers, divestments, ERP implementations, negotiations, product launches, entering new markets) and has very strong intercultural and language skills (fluent English, German, French, Spanish). He has international work experience (Switzerland, France, USA, Germany) and is frequently leading projects with partners across Asia, eg. in Singapore, Korea and other countries.

A chemist by training (PhD in Physical Chemistry, University of Bern), Frank underwent post graduate business training at Cranfield School of Management and Harvard Business School.

Prof. Dr.-Ing. Harald Augustin is Deputy Dean, Vice Dean for Corporate Relations & Alumni, Buildings & IT and professor at the ESB Business School, Reutlingen University. His fields of research and teaching are supply chain management, logistics engineering and supply chain management, Lean Warehousing, Green Warehousing, factory planning and the Digital Factory as well as information and communication systems for the Virtual Collaborative Engineering. In this subject he is head of the Virtual Engineering and Training Center VETC at the ESB Business School. He is also the Director of the Steinbeis Transfer Center Process Management in Gomaringen, Germany, and senior consultant and management coach in the fields of production, logistics and collaboration management in virtual engineering teams. After his studies in mechanical engineering at the Technical University Karlsruhe, Germany, in France, Australia and Canada and his PhD work his main working engagements have been ERP specialist at the Nuclear Research Center Karlsruhe, Managing Director of the Center of Production Technology, Senior Project Manager for international logistics projects and Head of the Department “Logistics Distribution Centre Europe” at the Robert Bosch GmbH, finally responsible for the development of the European logistics strategy and the planning and implementation of the European Distribution Centre for the Power Tool Division. Additionally he is member of the German Engineering Association (VDI) and the German Logistics Association (BVL).

Key supply chain project you are currently working on:
Reorganisation of the supply chain from supplier to customer by building a new warehouse for production incomings and distribution of an international automotive supplier

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
How to integrate all customer requirements and also to meet all international security including risk management on all levels of the supply chain

What benefits do you plan to take home from LogiPharma?
To have interesting talks and get to know new aspects and solutions within the supply chain.

Jacques’s is specialized in supply chain planning & collaboration. He holds a master degree in information processing and started his career during 5 years in the high tech industry as a qualified electronics engineer before becoming a consultant specialized in manufacturing, just-in-time and logistics. He then focused on supply chain planning with various technologies, Numetrix, Manugistics, APO.

He worked for over 20 years within large management consulting firms (Ernst & Young, PricewaterhouseCoopers, Lodestone) in transforming supply chains in automotive, CPG and Pharmaceuticals. At PWC consulting he was heading the European Supply Chain Planning Practice.
He is now within Lodestone leading the integrated business planning consulting practice as well as being involved in key global transformation initiatives.

He is looking forward to share experience and ideas around how the new web 2.0 technologies can provide tremendous value for coping with the challenges of volatility in Pharma supply chain.

Julian Amey is a Principal Fellow at Warwick University with advisory responsibilities for supply chain and operations management.

Julian joined ICI in 1978 as a Control Engineer after studying General Engineering at University followed by postgraduate Production Management.

After roles in project engineering, maintenance engineering and production management, he was seconded to ICI Pharmaceuticals US in the late 1980s with responsibility for production planning. He returned to the UK in 1991 with responsibilities for aseptic manufacture and new product introduction.

In 1994 Julian coordinated a major supply chain re-engineering programme for Zeneca Pharmaceuticals until, in 1998 he headed up Zeneca’s Supply Chain Group. At the merger with Astra in 1999 Julian was appointed Vice President of Supply Chains & Logistics. From 2002-2004 he led work to establish the AstraZeneca Supply System, defining and implementing lean approaches to the way AstraZeneca conducts its Supply Chain activities.

During 2005 and 2006 Julian was seconded to Global Development within R&D to lead and support change activities, before returning to Operations to lead the Transformation & Strategy Group. From 2008 he took on the leadership of the Global Supply Chain. He retired from AstraZeneca at the end of 2009 and joined Warwick University in 2010. In addition, Julian consults in supply chain management.

Julian lives in Cheshire, UK and is married with twin boys aged 12.

Jyrki Syväri, Pharmacist and Chemist, made his PhD Theses in Pharmaceutical Chemistry and his Diploma in Chemistry in Analytical Chemistry. He joined Schering AG in Berlin and headed there a R&D Laboratory for the development of parenteral drugs. He left Schering AG to join Boehringer Ingelheim (corporate headquarters), where he became a Project Manager in Operations. He was responsible for the world-wide launches of new products, such as Metalyse and Spiriva. Thereafter he was heading a group called “Launch and Special Supplies”. In this function he was responsible for setting up supply chains for Boehringer Ingelheim’s new products. New Supply Chain paradigms and concepts fell also under his responsibility. In this context he became the world-wide project leader for BI’s Product Safety & Security project that centres around serialisation.

Major challenge in 2012 will be to move serialization at Boehringer Ingelheim from “Pilot to world-wide implementation and routine”. My intention to go the LogiPharma event is to meet people with similar challenges in serialization & aggregation and to up-date my supply chain management knowledge.

Lars Junker has been working with SCM and planning tools since 1997. His background is an Engineer within production and logistics. For more than 10 years he held the position as SCM Solution Adviser at SAP Nordic. The resent years Lars has focused on developing support offering around implementation and maintenance of advanced planning processes and solutions in NNIT.

Leif Kronkvist is the senior vice president of business development for GIL Europe and Area West. Mr. Kronkvist is responsible for business development and customer relationship management in Europe.

He is also responsible for the development of trade lanes to Asia, North America, Europe and the Middle East.

Mr. Kronkvist brings extensive regional experience with his previous role as lead for Agility’s European tender and implementation team from 2007 to 2009.

With over 20 years of experience in the transportation industry in Europe, Mr. Kronkvist has served in a variety of roles at several international companies. Prior to joining Agility, Mr. Kronkvist was the head of global tender and implementation management at Schenker AG in Essen (Germany).

Mr. Kronkvist has a bachelor's degree in market economics from the IHM Business School Gothenburg, Sweden.

Initially graduated as engineer in electro-mechanics and holding an MBA in industrial management, Ludovic joined Baxter in 1995 and since then he has fulfilled several roles within the Supply Chain organization.

He has experience in the production area, planning & deployment, demand & forecasting, European and ECEMEA inventory management.

From 2001, he is managing the transport department covering Europe, Middle East and Africa controlling Intercompany shipments, replenishment flows and Customer facing distribution.

Early 2009 his Baxter team won the:

- Best Supply Chain Team Award –Baxter EMEA
- Environmental Health and Safety Best Partner Award First Place – Baxter Global
- CLECAT / FIATA Prize for Innovation in Transport and Logistics along the Global Supply Chain.

Mike Meakin has over 30 years experience in logistics working around the world. His last 20 years experience has been within highly regulated Pharmaceuticals, and Chemical supply chains; including wholesale operations.

Mike has spent the over 10 years with DHL & Exel previously focused in Life Science and Healthcare industry sector covering biologics, medical devices and pharmaceuticals.

The last 7 years Mike has been the sector’s head for Quality & Regulatory matters starting as Director and has the Vice President for Quality & Regulatory Affairs for the last 4 years.

During that time Mike has written numerous articles around Good Distribution Practices, reducing risks in the cold chain, patient safety and DHL pilots on enhancing its temperature assurance capabilities. His latest article on GDP was in Japan’s Pharm Tech in December 2011. He has also chaired and presented at a number of pharmaceutical events around the world.

Mike is further involved in a number of industry groups including GS1 Healthcare and is a member of TOPRA, RAPs, ISPE.

After his degree in Business Administration with a major in Marketing at the Università Commerciale Luigi Bocconi of Milan in 1990, Paolo Rosanna started his career in international Freight Forwarding in the UK, USA and Italy with MSAS Cargo International. Paolo has developed his expertise both in operations and business development, focusing on Life Sciences & Healthcare, following the company in its re-organizations and integrations with Exel in 2003 and with DHL in 2006. At the beginning of 2007 Paolo moved from DHL’s Global Forwarding Division to DHL Supply Chain, the contract logistics arm of DHL, when he was appointed Business Development Director for Italy. After two years in the roles of Head of Life Sciences & Healthcare Development Mainland Europe and Vice President Business Development Western Europe, Paolo has been appointed from January 2012 in leading the agenda of Business Development of Life Sciences & Healthcare Sector in EMEA.

Paolo was born in Stresa, Italy, in 1965 and is married with two sons. In his spare time he is passionate about football.

Prashant Yadav is a Senior Research Fellow and Director of the Health Care Research Initiative at the William Davidson Institute (WDI) at the University of Michigan. He also is on the faculty at the Ross School of Business and the School of Public Health at the University of Michigan. A leading expert on pharmaceutical and healthcare supply chains in developing countries, Dr. Yadav research explores the functioning of healthcare supply chains using a combination of empirical, analytical and qualitative approaches. He is the author of many scientific publications and his work on healthcare supply chains has been featured in prominent print and broadcast media. He also serves on the boards and advisory committees of multiple global health organizations. Prior to coming to the William Davidson Institute at the University of Michigan, Dr. Yadav was a Professor of Supply Chain Management at the MIT-Zaragoza International Logistics Program and a Research Affiliate at the MIT Center for Transportation and Logistics where he led the creation of a high impact research initiative focused on pharmaceutical supply chains in developing countries. From 2008-2010 he was also a visiting scholar at the INSEAD Social Innovation Center.

Key supply chain project you are currently working on:
Improving the supply chain for vaccines and medicines for infectious diseases in remote regions of less developed countries

What is your major investment area within the supply chain?
Investments in creating better supply chain information flow networks and creating better incentives for different stakeholders across the supply chain.

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Stock outs of medicines, and lack of cold chain for vaccines are the major challenges being faced. Integrated supply chain structures and stronger incentives to invest in in-country supply chains will help us overcome these challenges.

What benefits do plan to take home from LogiPharma?
Perspectives of multiple experts in this sector on the unique challenges we face in supply chains in emerging markets and ways others have addressed them .

Richard’s career has focused on global supply chain management for over 28 years, encompassing Life Sciences, Chemicals and Consumer Goods industries. A qualified Chemical Engineer, his early career was spent with the ICI Group of Companies where he fulfilled a wide range of roles including plant management, process engineering, operations excellence and strategic sourcing. In 1996, he joined the PricewaterhouseCoopers business consulting team, where he focused primarily on business restructuring, post merger integration and the design of operating models for global product supply. Richard recently joined the Lodestone Management Consulting team as Partner with responsibility for further extending their global supply chain business consulting capabilities.

Salvatore Paparelli joined Sony Italia in 1989 in the Marketing Department. In 1997 he moved to Sony Europe HQ in Cologne to be in charge of Pan European Accounts and later in 1999 he was appointed General Manager of Sales Channel Management Europe in the newly established Sony Berlin HQ. In 2002 he took over the responsibility of European Sales of Consumer product in the function of Director, until 2004, when he moved back to Sony Italia covering the responsibility of Local Operations.

In 2008 he was appointed as Vice President ANIE – ICT – CE (the local Association of Electronic Industry). Also in the year, he created the company EDIEL that through investment of Industrial and Distribution Associations, promotes and implement paperless cycles in the Italian Electronic Industries.
In 2009, always in Sony he took over the responsibility of Sales Director keeping the role of Operations Director.

On the first of January 2011 he was appointed President and Managing Director of Sony Italy.
In November 2011 he become member of the Board of Director in Digital Confindustria.

Key supply chain project you are currently working on:
The consumers Electronics market is heavily affected by a huge cost and sales pressure which require a reengineering of the whole supply chain operations. This forces our organization to design a continuous better process. This is the key challenge we face today.

What is your major investment area within the supply chain?
Major investments today are focused on the security sector and warehouse optimization

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
With the contraction in demand and the increase of costs the next 12/18 months will need to have huge focus on procurement and last mile optimization so mainly on the two extreme of the whole supply chain process

What benefits do you plan to take home from LogiPharma?
Pharma logistic business model is more advanced compared to the consumer electronics business for both the nature of the goods and the imposed law rules in certain segments therefore the speed and the standardization must be to certain extend copied by the consumer goods business.

Vice President of Global Supply Chain Quality at Roche Diagnostics based in Mannheim, Germany. Holding two University Degrees in Economics (International Trade & Business Management).

With global responsibility he provides competent expertise in Business and Quality & Regulatory subjects across the International Supply Chain Operations, including Material Flow Planning, Procurement, Warehousing, Distribution, Order Handling, Contractor Management and Marketing.

He has proven skills in various management roles and functions with leadership competences. He is proactive and innovative with in-depth knowledge of global /local markets, customersand regulatory trends.

Before working at Roche, he worked for Henkel KG and SmithKline Beecham (currently GSK). He is a highly-acclaimed international keynote speaker and is regularly featured at a variety of high-profile conferences and trainings all over the world, which include: TRAX & Logipharma; ECA (European Compliance Academy); IPA (International Pharmaceutical Association, Canada); Cold Chain Management for Pharmaceuticals, Toronto; Cold Chain Distribution and Warehousing, Brussels; Cold Chain Management Summit, Shanghai; Warehouse and Distribution Centres, Shanghai; LogiPharma Conference, Philadelphia; Good Distribution.

Practice and Cold Chain Management, Vienna; Transport and Cold Management, Toronto. He also writes scientific articles for various pharmaceutical magazines such as ‘American Pharmaceutical Outsourcing’ and ‘World Pharmaceutical Frontier’.

Yoram has an MBA in Economics and Business Administration.

He has vast experience in global transportation systems and processes including all modes of transportation, Forwarding, Customs compliance programs, GDP and temperature management, Security, Safety and Environment implications.

Yoram has specialized in the Pharma and API industries including clinical trials, medical devices and bio pharmaceuticals.